Editas Medicine, Inc. EDIT 深 沪
已收盘 07-02 16:00:00 美东时间
3.65
+0.370
+11.28%
华盛通- 最 高3.68
- 今 开3.33
- 成交量 420.16万股
- 最 低 3.3165
- 昨 收 3.28
- 总市值 5.60亿
- 52周最高 4.5372
- 市盈率 静 --
- 换手率 2.74%
- 52周最低 1.66
- 委 比 -18.72%
- 总股本 1.53亿
- 历史最高 99.95
- 量 比 1.23
- 振 幅 11.08%
- 历史最低 0.9101
- 每 手 1
- 风险率 0.52%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Rivian Automotive, Tenax Therapeutics, Robinhood And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining around 450 points on Thursday. Shares of Rivian Automotive Inc (NASDAQ:RIVN) rose sharply on Thursday after the company released second-quarter production and delivery figures and raised full year delivery forecast. The company produced 12,61...
07-02 22:24
高脂血症，基因编辑药企：融资1.25亿美元
本文不构成任何投资意见和建议，以官方/公司公告为准；本文仅作医疗健康相关药物介绍，非治疗方案推荐（若涉及），不代表平台立场。任何文章转载需得到授权。 药融圈数据...
06-07 10:30
美股牛股 | VTIX飙升46%，获美国空军SBIR项目资金支持；360数科大涨25%
VTIX飙升46%，获美国空军SBIR项目资金支持；APPS大涨38%，财报强劲，美银称其增长前景清晰；360数科大涨25%，用户规模稳步扩容，信贷投放有所收缩>>
05-28 19:22
Abercrombie & Fitch Upbeat Q1 Earnings, Joins Digital Turbine, Dycom Industries And Other Big Stocks Moving Higher On Wednesday
Dow Jones up 300 points with gains from Abercrombie & Fitch, Digital Turbine, Dycom Industries, Qfin Holdings, Editas Medicine, and others.
05-27 22:51
Editas Medicine Prices $125M Public Offering Of 55.6M Shares And Warrants At $2.25 Each
Editas Medicine, Inc. (NASDAQ:EDIT), a pioneering gene editing company developing transformative medicines for serious diseases, today announced the pricing of an underwritten public offering of 55,555,556 shares of its
05-26 21:08
Editas Medicine stock dips on proposed equity offering
Editas Medicine (EDIT) shares fell nearly -12% premarket on Tuesday after the gene editing company launched an underwritten public offering of its common stock (or pre-funded warrants to purchase shar...
05-26 18:53
BUZZ-Editas Medicine tumbles after launching equity offering
BUZZ-Editas Medicine tumbles after launching equity offering ** Gene editing firm Editas Medicine EDIT.O shares down 16.3% in premarket trading on Tues to $2.31 as it looks to raise equity ** Cambridge, Massachusetts EDIT commences offering of stock, or pre-funded warrants, and accompanying warrants
05-26 18:39
Editas Medicine Launches Public Stock Offering to Raise Capital
Editas Medicine, Inc. (NASDAQ:EDIT), a pioneering gene editing company developing transformative medicines for serious diseases, today announced that it has commenced an underwritten public offering of its common stock
05-26 18:19
Editas Reports Cholesterol-Lowering Results for Experimental Gene Therapy
Editas Medicine, Inc. (NASDAQ:EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, presented new preclinical data for EDIT-401, its lead in vivo development
05-26 18:11
Editas Medicine Announces Proposed Public Offering
Editas Medicine, a gene editing company, has initiated an underwritten public offering of its common stock and accompanying warrants. Cantor and Wells Fargo Securities are serving as joint book-running managers. The offering is subject to market conditions and is being conducted under an effective shelf registration statement on Form S-3. A preliminary prospectus supplement will be available on the SEC’s website. Editas Medicine is focused on dev...
05-26 10:15
